首页 | 本学科首页   官方微博 | 高级检索  
     


Novel CERKL variant in consanguineous Jordanian pedigrees with inherited retinal dystrophies
Authors:Belal Azab  Raghda Barham  Dema Ali  Zain Dardas  Lana Rashdan  Maysa Bijawi  Ranad Maswadi  Abdelhalim Awidi  Hanan Jafar  Mohammed Abu-Ameerh  Muawyah Al-Bdour  Sami Amr  Abdalla Awidi
Affiliation:2. Clinical Laboratory Sciences Department, School of Science, The University of Jordan, Amman, Jordan;3. London School of Hygiene and Tropical Medicine, London, United Kingdom;4. Ophthalmology Department, Jordan University Hospital, The University of Jordan, Amman, Jordan;5. Department of Medicine and Hematology, Jordan University Hospital, The University of Jordan, Amman, Jordan.
Abstract:

Objective

To identify the disease-causing variants in 2 families with autosomal recessive inherited retinal dystrophies (IRDs) and to characterize phenotypic variability across the affected family members.

Design

Exome sequencing and ophthalmic clinical examination study.

Participants

Six members from 2 consanguineous Jordanian families with IRD.

Methods

Ophthalmic examinations and whole-exome sequencing (WES) were performed to identify IRD-causing variants in affected individuals from each family, followed by segregation analysis of candidate variants in affected and unaffected family members by Sanger sequencing.

Results

We identified 2 different homozygous deletion variants in CERKL in each family: a novel pathogenic variant, c.450_451delAT, and a known variant, c.1187_1188delTG. Both variants co-segregated with the disease in all affected family members. The resulting phenotypes further supported that CERKL is associated with cone–rod dystrophy (CRD) rather than retinitis pigmentosa (RP), as originally established.

Conclusion

Our study expands the genotypic spectra of CERKL variants, providing insights into the relevant pathogenesis of RP/CRD. We also confirm that the WES approach is a valuable tool for the molecular diagnosis of retinopathies.
Keywords:Correspondence to Belal Azab, PhD, Cell Therapy Center, The University of Jordan, Amman 11942, Jordan,   Abdalla Awidi, MD, Cell Therapy Center, The University of Jordan, Amman 11942, Jordan,
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号